Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.75B | $3.99B | $3.99B | $4.03B | $3.34B | $4.23B | $3.92B | $3.96B | $3.79B | $3.68B |
| Revenue growth | — | 6.6% | -0.2% | 1.1% | -17.1% | 26.7% | -7.3% | 1.1% | -4.3% | -3.0% |
| Gross profit | $2.00B | $2.19B | $2.07B | $2.17B | $1.66B | $2.35B | $2.13B | $2.09B | $1.96B | $1.84B |
| Gross margin | 53.4% | 54.8% | 51.9% | 53.7% | 49.6% | 55.5% | 54.2% | 52.6% | 51.6% | 50.0% |
| Operating income | $455M | -$1.56B | -$958M | $361M | -$3.00M | $608M | -$937M | -$85.0M | -$879M | -$422M |
| Operating margin | 12.1% | -39.1% | -24.0% | 9.0% | -0.1% | 14.4% | -23.9% | -2.1% | -23.2% | -11.5% |
| Net income | $430M | -$1.55B | -$1.01B | $263M | -$73.0M | $411M | -$950M | -$132M | -$910M | -$598M |
| Net margin | 11.5% | -38.8% | -25.4% | 6.5% | -2.2% | 9.7% | -24.2% | -3.3% | -24.0% | -16.3% |
| EPS (diluted) | $1.94 | -$6.76 | -$4.51 | $1.17 | -$0.33 | $1.87 | -$4.41 | -$0.62 | -$4.48 | -$3.00 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $563M | $602M | $500M | $633M | $649M | $657M | $517M | $377M | $461M | $235M |
| Capital expenditures | $125M | $144M | $183M | $123M | $87.0M | $142M | $149M | $149M | $180M | $131M |
| Free cash flow | $438M | $458M | $317M | $510M | $562M | $515M | $368M | $228M | $281M | $104M |
| Share buybacks | $814M | $401M | $250M | $260M | $140M | $200M | $150M | $300M | $250M | $0.00 |
| Dividends paid | $64.6M | $78.3M | $79.0M | $81.0M | $88.0M | $92.0M | $104M | $116M | $126M | $128M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $384M | $321M | $310M | $405M | $438M | $339M | $365M | $334M | $272M | $326M |
| Total assets | $11.6B | $10.4B | $8.69B | $8.60B | $9.34B | $9.24B | $7.64B | $7.37B | $5.75B | $5.43B |
| Total liabilities | $3.43B | $3.75B | $3.55B | $3.51B | $4.37B | $4.24B | $3.83B | $4.08B | $3.81B | $4.09B |
| Long-term debt | $1.51B | $1.61B | $1.56B | $1.43B | $1.98B | $1.91B | $1.83B | $1.80B | $1.59B | $2.02B |
| Shareholders' equity | $8.11B | $6.62B | $5.12B | $5.09B | $4.97B | $5.00B | $3.81B | $3.29B | $1.94B | $1.34B |
| Retained earnings | $3.95B | $2.32B | $1.23B | $1.40B | $1.23B | $1.51B | $456M | $205M | -$835M | -$1.56B |
| Shares (wtd avg diluted) | 222M | 229M | 224M | 224M | 219M | 220M | 216M | 212M | 203M | 199M |
Every figure is extracted from DENTSPLY SIRONA Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.